{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01166269",
      "orgStudyIdInfo": {
        "id": "ILIT"
      },
      "organization": {
        "fullName": "Rigshospitalet, Denmark",
        "class": "OTHER"
      },
      "briefTitle": "Study to Asses Efficacy of Intralymphatic Immunotherapy",
      "officialTitle": "Intralymphatic Specific Immunotherapy - as a New Treatment Form for Grass-pollen Allergic Subjects",
      "acronym": "ILIT"
    },
    "statusModule": {
      "statusVerifiedDate": "2012-11",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2010-07"
      },
      "primaryCompletionDateStruct": {
        "date": "2012-11",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2012-11",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2010-07-20",
      "studyFirstSubmitQcDate": "2010-07-20",
      "studyFirstPostDateStruct": {
        "date": "2010-07-21",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2012-11-07",
      "lastUpdatePostDateStruct": {
        "date": "2012-11-08",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Professor, Dr. Med Hans-Joergen Malling",
        "investigatorTitle": "Professor Dr. Med.",
        "investigatorAffiliation": "Rigshospitalet, Denmark"
      },
      "leadSponsor": {
        "name": "Rigshospitalet, Denmark",
        "class": "OTHER"
      },
      "collaborators": [
        {
          "name": "TRYG Foundation",
          "class": "OTHER"
        }
      ]
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "The purpose of the study is to try a new route for specific immunotherapy (SIT). The current treatment form for SIT is subcutaneously (SCIT), which is a long treatment with up to 50 injections subcutaneously in the upper arm.\n\nThe investigators believe that there is additional effect if the allergen is injected directly into the lymph node, since it is here, the allergen presentation is happening. The trial has been performed in Switzerland with significant effect of only three injections of grass-allergen into a lymph node (Clinicaltrials.gov; NCT00470457).\n\nThe investigators would like to see what happens if the the dose is doubled, so the patients will receive 6 injections all in all, with the same amount of allergen as the earlier study (1000 SQ-U). Also the outcome measurements is slightly different as the patients will note their symptoms in a diary.\n\nThe patients will be divided into three groups using allocation:\n\n1 group with 6 injections of allergen\n\n1 group with 3 injections of allergen and 3 injections of placebo\n\n1 group with 6 injections of placebo. The trial will be double blinded."
    },
    "conditionsModule": {
      "conditions": [
        "Allergy"
      ],
      "keywords": [
        "grass-pollen allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2",
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 44,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Grass-Allergen x 6",
          "type": "EXPERIMENTAL",
          "description": "This arm will receive 6 injections of allergen.",
          "interventionNames": [
            "Biological: phleum pratense (grass-allergen)"
          ]
        },
        {
          "label": "grass-allergen x 3 and placebo x 3",
          "type": "ACTIVE_COMPARATOR",
          "description": "this arm will receive 3 injections of allergen, and 3 injections of placebo.",
          "interventionNames": [
            "Biological: phleum pratense (grass allergen)"
          ]
        },
        {
          "label": "placebo x 6",
          "type": "PLACEBO_COMPARATOR",
          "description": "this arm will receive 6 injections of placebo.",
          "interventionNames": [
            "Other: physiological saline"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "phleum pratense (grass-allergen)",
          "description": "6 injections of grass-allergen. Every dose will be 1000 SQ-U.",
          "armGroupLabels": [
            "Grass-Allergen x 6"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "phleum pratense (grass allergen)",
          "description": "3 injections of grass-allergen. Every dose will be 1000 SQ-U. Also 3 injections of placebo (physiological saline)",
          "armGroupLabels": [
            "grass-allergen x 3 and placebo x 3"
          ]
        },
        {
          "type": "OTHER",
          "name": "physiological saline",
          "description": "6 injections of placebo (physiological saline)in a lymph node.",
          "armGroupLabels": [
            "placebo x 6"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "symptom improvement",
          "description": "The patients will fill out a diary during the grasspollen-season before and after treatment. Also they will fill out a form for the general status of the season passed.",
          "timeFrame": "2 seasons. (2 years)"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Improvement of reactivity of skin prick test and Specific IgE",
          "timeFrame": "2 years"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* grass pollen allergy through at least 2 seasons\n* positive skin prick test\n* positive Specific IgE of at least 2. (CAP)\n* Signed informed consent\n* for females a negative pregnancy test.\n\nExclusion Criteria:\n\n* out of age limits\n* rhinoconjunctivitis all year round.\n* uncontrolled seasonal asthma\n* patients treated with steroids continuously or beta-blockers.\n* pregnancy and breastfeeding\n* HIV, Hepatitis B+c, and other immunological diseases.\n* psychiatric disease\n* treatment with SCIT or SLIT within the last 5 years\n* participation in other clinical trials within the last 3 months.",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "60 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Hans-Joergen Malling, Prof. Dr. Med.",
          "affiliation": "Copenhagen University Hospital, Gentofte, Denmark",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Dermato-allergological dept. K",
          "city": "Gentofte Municipality",
          "state": "Hellerup",
          "zip": "2900",
          "country": "Denmark",
          "geoPoint": {
            "lat": 55.74903,
            "lon": 12.54601
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C095238",
          "term": "PHLPVI protein, Phleum pratense"
        }
      ]
    }
  },
  "hasResults": false
}